Cephradine
SIAL/BP063 - British Pharmacopoeia (BP) Reference Standard
Synonym: Cefradin
CAS Number: 38821-53-3
Empirical Formula (Hill Notation): C16H19N3O4S
Molecular Weight: 349.40
MDL Number: MFCD00865048
Linear Formula: C16H19N3O4S
Product Type: Chemical
API family | cephradine |
application(s) | pharmaceutical pharmaceutical small molecule |
form | crystalline powder |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C16H19N3O4S/c1-8-7-24- |
InChI key | RDLPVSKMFDYCOR-UEKVPHQBSA |
manufacturer/tradename | BP |
shelf life | limited shelf life, expiry date on the label |
SMILES string | [H][C@]12SCC(C)=C(N1C(=O) |
storage temp. | 2-8°C |
Application: | Cephradine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as: • Ampicillin Injection • Ampicillin Capsules • Cefalexin Oral Suspension • Cefalexin Capsules • Cefalexin Tablets • Cefradine Oral Suspension • Cefradine Capsules • Cefradine Injection |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. |
Other Notes: | Sales restrictions may apply. |
Packaging: | Unit quantity: 300 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia |
Symbol | GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H315 - H317 - H319 - H334 - H335 |
Precautionary statements | P261 - P264 - P280 - P284 - P304 + P340 + P312 - P342 + P311 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |